Related Experiment Video
Updated: Jan 7, 2026

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice
Published on: October 18, 2024
Relationships Between Metabolic and Bariatric Surgery and Adverse Kidney Outcomes: An Analysis of a Retrospective
Kevin C Maki1,2, Stephanie L Dickinson3, Carol F Kirkpatrick1,4
1Midwest Biomedical Research Addison Illinois USA.
Objective:
Obesity is associated with an increased risk of chronic kidney disease. Metabolic and bariatric surgery (MBS) is currently the most effective intervention for sustained weight loss and may reduce the risk of obesity-associated kidney disease. This study examined the relationships between MBS and adverse kidney outcomes.
Methods:
This retrospective cohort analysis included 4322 patients with obesity, with or without type 2 diabetes mellitus (T2D), who underwent MBS, and 30,919 nonsurgical control patients from a large health system within the state of Indiana. A primary kidney composite [≥ 1 estimated glomerular filtration rate (eGFR) < 15 mL/min/1.73 m2, ≥ 1 eGFR measurement with a ≥ 40% decrease from baseline, or kidney failure-related death], as well as secondary and tertiary composite and individual outcomes were assessed. Multivariable Cox regression models with and without inverse propensity of treatment weighting were employed to assess associations between MBS and incidence rate for each kidney outcome compared with nonsurgical controls.
Results:
The mean (standard deviation) follow-up duration was 6.1 (4.5) years. MBS was associated with a 53% (HR: 0.47; 95% CI: 0.42, 0.52; p < 0.001) and 48% (HR: 0.52; 95% CI: 0.46, 0.60; p < 0.001) lower incidence of the primary kidney composite outcome in patients with and without T2D, respectively, and 48%-56% lower risks for the secondary and tertiary outcomes, regardless of T2D status, compared to controls.
Conclusions:
MBS was associated with markedly lower risks for adverse kidney outcomes in patients with obesity. These results support the potential for MBS as a weight loss intervention to preserve kidney function in patients with obesity, both with and without T2D.
Insights
Metabolic and bariatric surgery (MBS) significantly reduces the risk of adverse kidney outcomes in patients with obesity. This weight loss intervention helps preserve kidney function, even in those with type 2 diabetes.
Area of Science:
- Nephrology
- Metabolic Surgery
- Obesity Medicine
Background:
- Obesity is a major risk factor for chronic kidney disease (CKD).
- Metabolic and bariatric surgery (MBS) is an effective intervention for sustained weight loss.
- MBS may mitigate the risk of kidney disease associated with obesity.
Purpose of the Study:
- To investigate the association between MBS and adverse kidney outcomes.
- To compare kidney outcomes in obese patients who underwent MBS versus those who did not.
Main Methods:
- Retrospective cohort analysis of 4322 patients undergoing MBS and 30,919 non-surgical controls.
- Assessment of primary kidney composite outcomes, including low estimated glomerular filtration rate (eGFR), significant eGFR decline, or kidney failure-related death.
- Multivariable Cox regression models, with and without inverse propensity of treatment weighting, were used to analyze data.
Main Results:
- MBS was linked to a 53% lower incidence of the primary kidney composite outcome in patients with type 2 diabetes (T2D) and a 48% reduction in those without T2D.
- Patients undergoing MBS experienced 48%-56% lower risks for secondary and tertiary kidney outcomes, irrespective of T2D status.
- Follow-up averaged 6.1 years, demonstrating sustained benefits of MBS on kidney health.
Conclusions:
- Metabolic and bariatric surgery is associated with substantially reduced risks of adverse kidney outcomes in individuals with obesity.
- These findings support the use of MBS as a strategy to preserve kidney function in obese patients, including those with T2D.
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Kidney Transplant I: Introduction
Kidney Transplant III: Nursing Management
External Anatomy of the Kidney
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...

